N

Nuveen Portfolio holdings

AUM $379B
1-Year Est. Return 29.33%
This Quarter Est. Return
1 Year Est. Return
+29.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$362B
AUM Growth
+$32.2B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,484
New
Increased
Reduced
Closed

Top Buys

1 +$7.05B
2 +$2.25B
3 +$1.5B
4
AMZN icon
Amazon
AMZN
+$637M
5
CSCO icon
Cisco
CSCO
+$577M

Top Sells

1 +$2.48B
2 +$1.79B
3 +$699M
4
AAPL icon
Apple
AAPL
+$586M
5
BOLD
Boundless Bio
BOLD
+$399M

Sector Composition

1 Technology 32.84%
2 Financials 12.99%
3 Consumer Discretionary 11.23%
4 Communication Services 9.04%
5 Industrials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKTW icon
3376
MarketWise
MKTW
$35.7M
-2,138
MODV
3377
DELISTED
ModivCare
MODV
-31,196
MRAM icon
3378
Everspin Technologies
MRAM
$209M
-25,997
MRSN icon
3379
Mersana Therapeutics
MRSN
$144M
-9,289
NAUT icon
3380
Nautilus Biotechnolgy
NAUT
$245M
-193,591
NDVG icon
3381
Nuveen Dividend Growth ETF
NDVG
$13.6M
-220,000
NKTR icon
3382
Nektar Therapeutics
NKTR
$869M
-21,781
NMRA icon
3383
Neumora Therapeutics
NMRA
$302M
-220,970
NNBR icon
3384
NN Inc
NNBR
$63.2M
-62,006
NOTE icon
3385
FiscalNote
NOTE
$23.4M
-15,114
NRGV icon
3386
Energy Vault
NRGV
$836M
-272,886
NSCS
3387
DELISTED
Nuveen Small Cap Select ETF
NSCS
-220,000
NTIC icon
3388
Northern Technologies International Corp
NTIC
$71.1M
-10,495
NUAG icon
3389
Nuveen Enhanced Yield US Aggregate Bond ETF
NUAG
$70.1M
-1,234,319
NUGO icon
3390
Nuveen Growth Opportunities ETF
NUGO
$2.76B
-81,339,660
NULC icon
3391
Nuveen ESG Large-Cap ETF
NULC
$50.7M
-200,000
NWLG icon
3392
Nuveen Winslow Large-Cap Growth ESG ETF
NWLG
$11.9M
-220,000
OBIO icon
3393
Orchestra BioMed
OBIO
$238M
-41,729
OCGN icon
3394
Ocugen
OCGN
$462M
-756,926
ONL
3395
Orion Office REIT
ONL
$128M
-167,051
OPAD icon
3396
Offerpad Solutions
OPAD
$45.3M
-13,873
OPEN icon
3397
Opendoor
OPEN
$5.56B
-1,830,702
OVID icon
3398
Ovid Therapeutics
OVID
$118M
-119,113
PEPG icon
3399
PepGen
PEPG
$420M
-98,701
PLRX icon
3400
Pliant Therapeutics
PLRX
$75.6M
-233,585